Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects

Details for Australian Patent Application No. 2006289752 (hide)

Owner Otsuka Pharmaceutical Co., Ltd.

Inventors Hong, Ki Whan; Yoshikawa, Tomohiro

Agent Davies Collison Cave

Pub. Number AU-B-2006289752

PCT Pub. Number WO2007/032557

Priority 60/716,954 15.09.05 US; 60/761,775 25.01.06 US

Filing date 14 September 2006

Wipo publication date 22 March 2007

Acceptance publication date 9 June 2011

International Classifications

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61K 31/095 (2006.01) - Sulfur, selenium or tellurium compounds, e.g. thiols

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

24 April 2008 PCT application entered the National Phase

  PCT publication WO2007/032557 Priority application(s): WO2007/032557

9 June 2011 Application Accepted

  Published as AU-B-2006289752

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006289794-Electric motor and electric tool with the same

2006289751-Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity